Zoetis Inc.

Company Overview

Zoetis Inc. is the global leader in animal health, generating revenue by discovering, developing, manufacturing, and commercializing a diverse portfolio of medicines, vaccines, diagnostics, and genetic tests for both livestock and companion animals. The company leverages its extensive R&D capabilities and direct-to-veterinarian distribution model to maintain a strong market position. Its core competitive advantage lies in its comprehensive product offering, deep scientific expertise, and robust relationships within the veterinary community worldwide.

Revenue Structure

Zoetis generates revenue primarily from the sale of pharmaceuticals, vaccines, and diagnostic products for companion animals and livestock. Companion animal products, including parasiticides, vaccines, and therapeutics, generally represent a larger and faster-growing portion of its revenue. Livestock products, comprising vaccines, anti-infectives, and feed additives for cattle, swine, poultry, and fish, form the other significant component.

Key Risks

Key Points

Zoetis represents a robust investment opportunity as the global leader in the resilient animal health market, benefiting from increasing demand for animal protein and the growing human-animal bond. Its strong R&D pipeline, diversified product portfolio, and expanding global presence position it for continued long-term growth and stable cash flow generation.